1-3 of 3
Alain Sadoun, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Cell Lysis Mediated by LFB-R603 with That Mediated by Ofatumumab Against Cells Expressing Low Levels of CD20,

Anne Bellon, PharmD, PhD, Alain Sadoun, MD, Karine Grivel, MSc, Maxime Moulard, PhD, Frederique Brune, PharmD, Jean-Francois Prost, MD, Margarita Salcedo, PhD
Journal: Blood
Blood (2011) 118 (21): 3913.
https://doi.org/10.1182/blood.V118.21.3913.3913
Published: 2011
Journal Articles

Multicentre Phase I Study with an 8-Dose Regimen of Single Agent Anti-CD20 Monoclonal Antibody LFB-R603 in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Bruno Cazin, MD, Stéphane Leprêtre, MD, Bertrand Coiffier, Thérèse Aurran, MD, Guillaume Cartron, MD, PhD, Pierre Feugier, MD, PhD, Oana Brehar, MD, Alain Sadoun, MD, Fédéric Segaud, Vincent Ribrag, MD
Journal: Blood
Blood (2011) 118 (21): 2862.
https://doi.org/10.1182/blood.V118.21.2862.2862
Published: 2011
Journal Articles

A Phase I study of LFB-R603, a Novel Anti-CD20 Antibody, in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Guillaume Cartron, MD, PhD, Bruno Cazin, MD, Bertrand Coiffier, MD, PhD, Stéphane Leprêtre, MD, Pierre Feugier, MD, PhD, Thérèse Aurran, MD, Guylène Chartier, Alain Sadoun, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2010) 116 (21): 2447.
https://doi.org/10.1182/blood.V116.21.2447.2447
Published: 2010